Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study

被引：0
|
作者：
Chao Xu
Xiaoli Xie
Ning Kang
Huiqing Jiang
机构：
[1] The Second Hospital of Hebei Medical University,Department of Gastroenterology
[2] Handan Central Hospital,Department of Gastroenterology
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Locally advanced gastric cancer; Apatinib; Programmed cell death protein 1 inhibitor; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4091 / 4099
页数：8
相关论文
共 50 条
  • [41] A prospective, phase II, single-arm study of neoadjuvant/conversion therapy with camrelizumab, apatinib, S-1 ± oxaliplatin for locally advanced cT4a/bN+ gastric cancer.
    Li, Song
    Yu, Wenbin
    Xie, Fei
    Liu, Zhimin
    Lv, Weiwei
    Shi, Duanbo
    Yu, Dexin
    Wei, Meng
    Wang, Jiaqian
    Zhao, Yongtian
    Chen, Cheng
    Zhao, Zhikun
    Gao, Jing
    Sheng, Lei
    Liu, Lian
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Intraperitoneal Paclitaxel Combined with S-1 Plus Oxaliplatin for Advanced Gastric Cancer with Peritoneal Metastasis: a Phase I Study
    Kim, Dong-Wook
    Seo, Won Jun
    Youn, Sang Il
    Jee, Ye Seob
    Jang, You-Jin
    Kim, Jong-Han
    JOURNAL OF GASTRIC CANCER, 2021, 21 (04) : 418 - 425
  • [43] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Sato, Hirohiko
    Shimada, Mitsuo
    Kurita, Nobuhiro
    Iwata, Takashi
    Yoshikawa, Kozo
    Higashigima, Jun
    Chikakio, Motoya
    Kashihara, Hideya
    Takasu, Chie
    Matsumoto, Noriko
    Eto, Shozo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 543 - 548
  • [44] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Hirohiko Sato
    Mitsuo Shimada
    Nobuhiro Kurita
    Takashi Iwata
    Kozo Yoshikawa
    Jun Higashigima
    Motoya Chikakio
    Hideya Kashihara
    Chie Takasu
    Noriko Matsumoto
    Shozo Eto
    International Journal of Clinical Oncology, 2015, 20 : 543 - 548
  • [45] S-1 with leucovorin and oxaliplatin for advanced gastric cancer
    ter Veer, Emil
    van Oijen, Martijn G. H.
    van Laarhoven, Hanneke W. M.
    LANCET ONCOLOGY, 2016, 17 (02): : E41 - E41
  • [46] S-1 Combined with Oxaliplatin as First Line Chemotherapy for Chinese Advanced Gastric Cancer Patients
    Liu, Bixia
    Ying, Jieer
    Luo, Cong
    Xu, Qi
    Zhu, Liming
    Zhong, Haijun
    HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 649 - 653
  • [47] Results of a phase II multicenter study of neoadjuvant S-1 and irinotecan in patients with locally advanced gastric cancer
    Terashima, M.
    Saze, Z.
    Hosotani, R.
    Takahashi, M.
    Takagane, A.
    Hachiya, O.
    Koeda, K.
    Matsui, S.
    Ohashi, W.
    Gotoh, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
    Qiu, Zhi-Yuan
    Qin, Rong
    Tian, Guang-Yu
    Zhang, Zhao
    Chen, Meifang
    He, Han
    Xi, Yan
    Wang, Yan
    MEDICINE, 2021, 100 (17) : E25630
  • [49] First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study
    Chen, Xiaofeng
    Xu, Hao
    Chen, Xiaobing
    Xu, Tongpeng
    Tian, Yitong
    Wang, Deqiang
    Guo, Fen
    Wang, Kangxin
    Jin, Guangfu
    Li, Xiao
    Wang, Rong
    Li, Fengyuan
    Ding, Yongbin
    Tang, Jie
    Fang, Yueyu
    Zhao, Jing
    Liu, Liang
    Ma, Ling
    Meng, Lijuan
    Hou, Zhiguo
    Zheng, Rongrong
    Liu, Yang
    Guan, Ni
    Zhang, Bei
    Tong, Shuang
    Chen, Shiqing
    Li, Xing
    Shu, Yongqian
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [50] Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer
    Yamada, Yasuhide
    Koizumi, Wasaburo
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Tsuji, Akihito
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirofumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hironaka, Shuichi
    Shimada, Ken
    Hyodo, Ichinosuke
    CANCER SCIENCE, 2019, 110 (09) : 2875 - 2883
12345